ef4f5c35fb7dd28694ed7b0df17e87a7

ABD PAD

DIAGAST·IV·Ecuador ARCSA·Registered December 07, 2022
Device classification
Risk class
IV
Product type
In Vitro Diagnostic
Brand name
DIAGAST
Commercial name
19-294 IVD Reagents/Kits, Immunohematology, Blood Pooling
Registration information
Analysis ID
ef4f5c35fb7dd28694ed7b0df17e87a7
Registration date
December 07, 2022
Expiration date
December 07, 2027
Manufacturer
City
LOOS
Country
FRENCH
Address
251 AVENUE EUGENE AVINNEE, 59120 LOOS- FRANCE
Product owner
Name
DIAGAST
Country
FRENCH
Authorized representative
Address
BARRIO JIPIJAPA STREET: ISLA FERNANDINA NO. N42-40 INTERSECCION ISLA TORTUGA
Phone
2252800
Product use

ALLOWS THE CONTROL OF THE BLOOD GROUP ABO / RH (CONFIRMATION OR CONTROL PRE-DONATION), BY DETERMINING THE PRESENCE OF ERYTHROCYTE ANTIGENS A, B AND D ON THE SURFACE OF THE HUMAN HEMATIES.

About this record

Access comprehensive regulatory information for ABD PAD in the Ecuador medical device market through Pure Global AI's free database. This IV medical device is registered under ARCSA ID ef4f5c35fb7dd28694ed7b0df17e87a7 and manufactured by DIAGAST. The device was registered on December 07, 2022.

This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.